Cite
HARVARD Citation
Fautrel, B. et al. (n.d.). AB0395 Subcutaneous tocilizumab as monotherapy or in combination with a csdmard in patients with rheumatoid arthritis: 24 weeks results of the french phase iiib study, "tosca". Annals of the rheumatic diseases. pp. 1186-1187. [Online].